László Vécsei
László Vécsei is an expert in Neurology at University of Szeged (Hungary). As of October 2026, ScienceLeadR ranks László Vécsei in the top 1% of experts worldwide for Migraine Disorders, Headache Disorders and Autoimmune Diseases. László Vécsei has authored 785 publications, the most recent in 2026, and is an investigator in 12 clinical trials. SLR score: 2,403 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1987 - 2026
Number : 785
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Pharmacological Modulation of the Kynurenine Pathway Using PF-04859989 Modulates PACAP Signaling in Migraine-Relevant Trigeminal Sensitization. PMID 42650796 — pituitary adenylate cyclase-activating polypeptide, kynurenine, migraine disorders, neuropeptides, therapeutics, kynurenic acid | Biomolecules | 2026 | 0 |
| [Pituitary adenylate-cyclase activating polypeptide (PACAP)-targeting treatment as a potential migraine prophylactic therapy]. PMID 42554332 — pituitary adenylate cyclase-activating polypeptide, adenylyl cyclases, migraine disorders, receptors, calcitonin gene-related peptide, therapeutics, nervous system | Ideggyogy Sz | 2026 | 0 |
| The role of Kynurenine-Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) axis in migraine pathophysiology and therapy. PMID 42554331 — pituitary adenylate cyclase-activating polypeptide, adenylyl cyclases, tryptophan, kynurenine, migraine disorders, neuropeptides, therapeutics, nervous system, pathologic processes | Ideggyogy Sz | 2026 | 0 |
| The kynurenine pathway in depression and schizophrenia: convergent signals, divergent states, and clinical signatures. PMID 42454335 — depression, kynurenine, biomarkers, schizophrenia, psychiatry | EXCLI J | 2026 | 0 |
| Long-term cuprizone administration resulted in cognitive decline and kynurenine metabolic disturbance: novel findings. PMID 42303078 — remyelination, cuprizone, kynurenine, cognitive dysfunction, recycling, therapeutics, psychiatry | Prog Neuropsychopharmacol Biol Psychiatry | 2026 | 0 |
Clinical Studies 12
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
LeadR Networks
Main global connection map